SRx Health Solutions, Inc. (formerly Better Choice Company, Inc.) reported significant financial challenges in its latest 10-Q filing for the quarter ending June 30, 2025. The company recorded net sales of $11.4 million for the three months ended June 30, 2025, a substantial decrease of 73% compared to $42.7 million in the same period last year. For the nine months ending June 30, 2025, net sales were $41.1 million, down 65% from $117.1 million in the prior year. The decline in revenue was attributed to operational disruptions and liquidity constraints that limited the company’s ability to purchase and dispense high-cost specialty medications, leading to reduced patient volumes and prescription fulfillment rates.
The company's gross profit also saw a significant decline, dropping to $3.4 million for the three months ended June 30, 2025, compared to $9.4 million in the same period of 2024. For the nine-month period, gross profit decreased to $10.3 million from $23.4 million. The operating loss widened to $17.4 million for the quarter and $32.2 million for the nine months, compared to losses of $1.3 million and $8.2 million, respectively, in the prior year. Contributing to these losses were increased selling, general, and administrative expenses, which rose by 68% to $18.2 million for the quarter, driven by transaction-related costs associated with the recent merger and other operational challenges.
Strategically, SRx Health Solutions underwent a significant transformation with the completion of a reverse merger with Better Choice on April 24, 2025. This merger allowed SRx to consolidate its operations and expand its service offerings, particularly in specialty healthcare. However, the company has faced challenges in integrating these operations effectively, leading to a slowdown in acquisition activity and a focus on optimizing existing services. The company also reported a bargain purchase gain of $1.7 million related to the merger, which was recognized in the financial statements.
Operationally, SRx Health Solutions has been restructuring its business model, which includes the divestiture of non-core assets and a reduction in workforce to improve liquidity. As of June 30, 2025, the company had a working capital deficiency of $49.6 million and an accumulated deficit of $98.4 million. The company is currently in discussions with its lender, Canadian Western Bank, regarding non-compliance with financial covenants, which has resulted in the classification of its debt as current. In August 2025, SRx initiated proceedings under the Companies’ Creditors Arrangement Act (CCAA) in Canada to facilitate a court-supervised restructuring of its business.
Looking ahead, SRx Health Solutions aims to stabilize its operations and improve liquidity through various strategic initiatives, including potential capital raises and operational efficiencies. However, the company acknowledges that there is substantial doubt about its ability to continue as a going concern without additional financing or significant improvements in operational performance. The ongoing restructuring process and market conditions will play a critical role in determining the company's future trajectory.
About SRx Health Solutions, Inc.
Better Choice Company Inc. is a pet health and wellness company offering premium and super-premium dog and cat products under the Halo brand, including kibble, canned food, freeze-dried raw food, treats, oral care products, and supplements. Its products emphasize natural, sustainably sourced ingredients and science-based nutrition. Serving diverse channels—e-commerce, brick-and-mortar, direct-to-consumer, and international markets—the company leverages co-manufacturing partnerships and multi-channel distribution to reach pet owners focused on health and quality.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.